Virtual screening, identification, and biochemical characterization of novel inhibitors of the reverse transcriptase of human immunodeficiency virus type-1.

作者: Alon Herschhorn , Amnon Hizi

DOI: 10.1021/JM800473D

关键词: VirologyMolecular biologyDNA polymeraseVirusEnzyme inhibitorEnzymeReverse-transcriptase inhibitorChemistryRNA-Directed DNA PolymeraseReverse transcriptaseChemical library

摘要: The reverse transcriptase (RT) of human immunodeficiency virus type-1 (HIV-1) is a leading target in current antiretroviral therapy. Unfortunately, drug-resistant RT mutants evolve under the pressure these drugs, and therefore, new anti-RT inhibitors are constantly required for HIV-1/AIDS treatment. We virtually screened large chemical library compounds against two crystal structures HIV-1 to identify novel inhibitors. Top-scoring were tested experimentally; 71 inhibited RT-associated DNA polymerase, while several also pseudovirus infection cell-based assay. A combination substituents from structurally related single molecule improved inhibition efficacy. This compound strongly suppressed activity protecting lymphocytes infection. by this was reversible noncompetitive. another unrelated potent known mutant affected moderately HIV-2 polymerase. These may serve as promising anti-HIV lead compounds.

参考文章(38)
Paul A. J. Janssen, Paul J. Lewi, Eddy Arnold, Frits Daeyaert, Marc de Jonge, Jan Heeres, Luc Koymans, Maarten Vinkers, Jérôme Guillemont, Elisabeth Pasquier, Mike Kukla, Don Ludovici, Koen Andries, Marie-Pierre de Béthune, Rudi Pauwels, Kalyan Das, Art D. Clark,, Yulia Volovik Frenkel, Stephen H. Hughes, Bart Medaer, Fons De Knaep, Hilde Bohets, Fred De Clerck, Ann Lampo, Peter Williams, Paul Stoffels, In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine). Journal of Medicinal Chemistry. ,vol. 48, pp. 1901- 1909 ,(2005) , 10.1021/JM040840E
C. Ahgren, K. Backro, F. W. Bell, A. S. Cantrell, M. Clemens, J. M. Colacino, J. B. Deeter, J. A. Engelhardt, M. Hogberg, S. R. Jaskunas, The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. Antimicrobial Agents and Chemotherapy. ,vol. 39, pp. 1329- 1335 ,(1995) , 10.1128/AAC.39.6.1329
Jan Balzarini, A Karlsson, Anne-Mieke Vandamme, MJ Pérez-Pérez, H Zhang, Ll Vrang, B Oberg, K Bäckbro, T Unge, A San-Félix, Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro- 5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)]-beta-D-pentofurano syl (TSAO) nucleoside analogues retain sensitivity to HIV-1-specific nonnucleoside inhibitors. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 6952- 6956 ,(1993) , 10.1073/PNAS.90.15.6952
Jingshan Ren, Jonathan Diprose, Jonathan Warren, Robert M. Esnouf, Louise E. Bird, Shinji Ikemizu, Martin Slater, John Milton, Jan Balzarini, David I. Stuart, David K. Stammers, Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analyses. Journal of Biological Chemistry. ,vol. 275, pp. 5633- 5639 ,(2000) , 10.1074/JBC.275.8.5633
Neal W. Roehm, George H. Rodgers, Stephen M. Hatfield, Andrew L. Glasebrook, An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. Journal of Immunological Methods. ,vol. 142, pp. 257- 265 ,(1991) , 10.1016/0022-1759(91)90114-U
Maria Letizia Barreca, Angela Rao, Laura De Luca, Nunzio Iraci, Anna-Maria Monforte, Giovanni Maga, Erik De Clercq, Christophe Pannecouque, Jan Balzarini, Alba Chimirri, Discovery of novel benzimidazolones as potent non-nucleoside reverse transcriptase inhibitors active against wild-type and mutant HIV-1 strains. Bioorganic & Medicinal Chemistry Letters. ,vol. 17, pp. 1956- 1960 ,(2007) , 10.1016/J.BMCL.2007.01.025
Venkat R. Gadhachanda, Baogen Wu, Zhiwei Wang, Kelli L. Kuhen, Jeremy Caldwell, Helmut Zondler, Harald Walter, Mark Havenhand, Yun He, 4-Aminopyrimidines as novel HIV-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. ,vol. 17, pp. 260- 265 ,(2007) , 10.1016/J.BMCL.2006.09.047
A Hizi, R Tal, M Shaharabany, S Loya, Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2. Journal of Biological Chemistry. ,vol. 266, pp. 6230- 6239 ,(1991) , 10.1016/S0021-9258(18)38108-0
E DECLERCQ, HIV-chemotherapy and -prophylaxis: new drugs, leads and approaches. The International Journal of Biochemistry & Cell Biology. ,vol. 36, pp. 1800- 1822 ,(2004) , 10.1016/J.BIOCEL.2004.02.015
Alon Herschhorn, Lena Lerman, Michal Weitman, Iris Oz Gleenberg, Abraham Nudelman, Amnon Hizi, De Novo Parallel Design, Synthesis and Evaluation of Inhibitors against the Reverse Transcriptase of Human Immunodeficiency Virus Type-1 and Drug-Resistant Variants. Journal of Medicinal Chemistry. ,vol. 50, pp. 2370- 2384 ,(2007) , 10.1021/JM0613121